InsidersTradesSigma
Total declarations
Companies
▲ Purchases (4 ops.)
▼ Sales (0 ops.)
Insider track record
OtherDisclosed buys
4
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-40.0%
Across 3 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the complete record of transactions filed by SHULMAN JOHN D. Officer active across 2 companies, notably Petros Pharmaceuticals, Inc.. Aggregated, 4 filings have been recorded. Split: 4 buys · 0 sell. Total volume traded: €96k. Activity tracked since 8 July 2026. The latest transaction was disclosed on 8 July 2026 (Acquisition). Regulator: SEC (Form 4). The full history is openly available.
Declarations4 total
100,000 shares@ US$1.10Common StockSEC:0001493152-26-032738:0
Ideal exit: 4 Apr 2027 (T+270)
145,773 shares@ €3.03875.2% of flowCommon Stock, par value $0.0001 per shareSEC:0001104659-22-000036:0
Ideal exit: 18 Sept 2022 (T+270)
500,000 shares@ €2.656515.7% of flowCommon Stock, par value $0.0001 per shareSEC:0001104659-21-144901:0
Ideal exit: 26 Aug 2022 (T+270)
1,661,807 shares@ €1.476729.0% of flowCommon Stock, par value $0.0001 per shareSEC:0001567619-21-018515:0
Ideal exit: 15 Jul 2022 (T+270)
4 of 4 declarations
About SHULMAN JOHN D
John D. Shulman is a director at Petros Pharmaceuticals, Inc.
